{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T10:01:26Z","timestamp":1790762486591,"version":"4.1.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinical-breast-cancer.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Breast Cancer"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.clbc.2026.09.001","type":"journal-article","created":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T23:32:21Z","timestamp":1788910341000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Incidence and Treatment Patterns of Pleomorphic Lobular Carcinoma in Situ: A Population-based Analysis After the Introduction of ICD-O-3 Code 8519\/2"],"prefix":"10.1016","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2133-2106","authenticated-orcid":false,"given":"\u0130smail","family":"Zihni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5549-4023","authenticated-orcid":false,"given":"Mehmet Zafer","family":"Sabuncuo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.clbc.2026.09.001_bib0001","first-page":"481","article-title":"Cancer statistics: breast cancer in situ","volume":"65","author":"Ward","year":"2015","journal-title":"CA Cancer J Clin"},{"issue":"3","key":"10.1016\/j.clbc.2026.09.001_bib0002","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1023\/A:1019950918046","article-title":"Changing incidence of lobular carcinoma in situ of the breast","volume":"75","author":"Li","year":"2002","journal-title":"Breast Cancer Res Treat"},{"issue":"24","key":"10.1016\/j.clbc.2026.09.001_bib0003","doi-asserted-by":"crossref","first-page":"5534","DOI":"10.1200\/JCO.2005.04.038","article-title":"Bilateral risk for subsequent breast cancer after lobular carcinoma-in-situ: analysis of surveillance, epidemiology, and end results data","volume":"23","author":"Chuba","year":"2005","journal-title":"J Clin Oncol"},{"issue":"9","key":"10.1016\/j.clbc.2026.09.001_bib0004","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1245\/s10434-017-5867-6","article-title":"Population-based analysis of breast cancer incidence and survival outcomes in women diagnosed with lobular carcinoma in situ","volume":"24","author":"Wong","year":"2017","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.clbc.2026.09.001_bib0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.breast.2026.104711","article-title":"Pleomorphic and florid lobular carcinoma in situ of the breast: a systematic review of current evidence and knowledge gaps","volume":"86","author":"Ferrucci","year":"2026","journal-title":"Breast"},{"issue":"7","key":"10.1016\/j.clbc.2026.09.001_bib0006","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1097\/01.MP.0000073974.42583.F7","article-title":"Frequent E-cadherin gene inactivation by loss of heterozygosity in pleomorphic lobular carcinoma of the breast","volume":"16","author":"Palacios","year":"2003","journal-title":"Mod Pathol"},{"issue":"6","key":"10.1016\/j.clbc.2026.09.001_bib0007","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1038\/s41379-019-0449-8","article-title":"Genetic analysis of pleomorphic and florid lobular carcinoma in situ variants: frequent ERBB2\/ERBB3 alterations and clonal relationship to classic lobular carcinoma in situ and invasive lobular carcinoma","volume":"33","author":"Shamir","year":"2020","journal-title":"Mod Pathol"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.001_bib0008","article-title":"Upgrade rates of variant lobular carcinoma in situ compared to classic lobular carcinoma in situ diagnosed in core needle biopsies: a 10-year single institution retrospective study","volume":"37","author":"Sen","year":"2024","journal-title":"Mod Pathol"},{"issue":"8","key":"10.1016\/j.clbc.2026.09.001_bib0009","article-title":"Clinical management and oncologic outcomes of pure pleomorphic and florid lobular carcinoma in situ of the breast: results from a large single institution experience","volume":"51","author":"Ferrucci","year":"2025","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.clbc.2026.09.001_bib0010","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s10549-025-07771-x","article-title":"Immediate and ipsilateral recurrence rates and treatment recommendations for patients with pleomorphic and florid lobular carcinoma in situ","volume":"213","author":"Middleton","year":"2025","journal-title":"Breast Cancer Res Treat"},{"issue":"8","key":"10.1016\/j.clbc.2026.09.001_bib0011","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1093\/annonc\/mdz173","article-title":"Early breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"30","author":"Cardoso","year":"2019","journal-title":"Ann Oncol"},{"issue":"10","key":"10.1016\/j.clbc.2026.09.001_bib0012","doi-asserted-by":"crossref","first-page":"3240","DOI":"10.1245\/s10434-013-3121-4","article-title":"Trends in incidence and management of lobular carcinoma in situ: a population-based analysis","volume":"20","author":"Portschy","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"61","key":"10.1016\/j.clbc.2026.09.001_bib0013","doi-asserted-by":"crossref","first-page":"103047","DOI":"10.18632\/oncotarget.21461","article-title":"Treatment and survival outcomes of lobular carcinoma in situ of the breast: a SEER population based study","volume":"8","author":"Cheng","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.clbc.2026.09.001_bib0014","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejca.2017.05.030","article-title":"Survival outcomes of patients with lobular carcinoma in situ who underwent bilateral mastectomy or partial mastectomy","volume":"82","author":"Xie","year":"2017","journal-title":"Eur J Cancer"},{"issue":"12","key":"10.1016\/j.clbc.2026.09.001_bib0015","doi-asserted-by":"crossref","first-page":"2867","DOI":"10.1002\/cam4.1244","article-title":"Clinicopathological characteristics and survival outcomes in pleomorphic lobular breast carcinoma of the breast: a SEER population-based study","volume":"6","author":"Yang","year":"2017","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.clbc.2026.09.001_bib0016","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ejso.2019.07.011","article-title":"Pre-operative management of pleomorphic and florid lobular carcinoma in situ of the breast: report of a large multi-institutional series and review of the literature","volume":"45","author":"Foschini","year":"2019","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/j.clbc.2026.09.001_bib0017","doi-asserted-by":"crossref","DOI":"10.1155\/tbj\/3580992","article-title":"Florid lobular carcinoma in situ: imaging characteristics and pathologic upgrade rates on surgical excision","volume":"2025","author":"Desai","year":"2025","journal-title":"Breast J"},{"issue":"9","key":"10.1016\/j.clbc.2026.09.001_bib0018","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1200\/JCO.2008.20.1681","article-title":"Increasing rates of contralateral prophylactic mastectomy among patients with ductal carcinoma in situ","volume":"27","author":"Tuttle","year":"2009","journal-title":"J Clin Oncol"},{"issue":"14","key":"10.1016\/j.clbc.2026.09.001_bib0019","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1002\/cncr.30644","article-title":"Breast cancer prevention strategies in lobular carcinoma in situ: a decision analysis","volume":"123","author":"Wong","year":"2017","journal-title":"Cancer"},{"issue":"5","key":"10.1016\/j.clbc.2026.09.001_bib0020","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176417","article-title":"Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status","volume":"12","author":"Mao","year":"2017","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.001_bib0021","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s13058-019-1219-8","article-title":"Associations of race and ethnicity with risk of developing invasive breast cancer after lobular carcinoma in situ","volume":"21","author":"Dania","year":"2019","journal-title":"Breast Cancer Res"},{"issue":"4","key":"10.1016\/j.clbc.2026.09.001_bib0022","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1158\/1055-9965.EPI-04-0849","article-title":"Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001","volume":"14","author":"Li","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"10.1016\/j.clbc.2026.09.001_bib0023","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1002\/cncr.21864","article-title":"Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001","volume":"106","author":"Li","year":"2006","journal-title":"Cancer"},{"issue":"1","key":"10.1016\/j.clbc.2026.09.001_bib0024","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41523-023-00585-4","article-title":"Defining features of hereditary lobular breast cancer due to CDH1 with magnetic resonance imaging and tumor characteristics","volume":"9","author":"Gamble","year":"2023","journal-title":"NPJ Breast Cancer"}],"container-title":["Clinical Breast Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001643?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1526820926001643?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T09:12:29Z","timestamp":1790759549000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1526820926001643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":24,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S1526820926001643"],"URL":"https:\/\/doi.org\/10.1016\/j.clbc.2026.09.001","relation":{},"ISSN":["1526-8209"],"issn-type":[{"value":"1526-8209","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and Treatment Patterns of Pleomorphic Lobular Carcinoma in Situ: A Population-based Analysis After the Introduction of ICD-O-3 Code 8519\/2","name":"articletitle","label":"Article Title"},{"value":"Clinical Breast Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clbc.2026.09.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}